Ranolazine for Congenital Long-QT Syndrome Type III

Ehud Chorin*, Dan Hu, Charles Antzelevitch, Aviram Hochstadt, Luiz Belardinelli, David Zeltser, Hector Barajas-Martinez, Uri Rozovski, Raphael Rosso, Arnon Adler, Jesaia Benhorin, Sami Viskin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Ranolazine for Congenital Long-QT Syndrome Type III'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science